Preventive	JJ	preventive JJ PennPOS
and	CC	and cc NUPOS
therapeutic	JJ	therapeutic JJ PennPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
thymosin	NN	thymosin NN PennPOS
b4	NN	b4 NN PennPOS
N-terminal	JJ	N-terminal JJ PennPOS
fragment	NN	fragment NN PennPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
bleomycin	NN	bleomycin NN PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
this	DT	this d NUPOS
study	NN	study NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
bleomycin	NN	bleomycin NN PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
was	VBD	be vbd NUPOS
utilized	VBN	utilize VBN PennPOS
to	TO	to p-acp NUPOS
investigate	VB	investigate VBP PennPOS
putative	JJ	putative JJ PennPOS
anti-fibrotic	JJ	anti-fibrotic JJ PennPOS
activity	NN	activity NN PennPOS
of	IN	of pp-f NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
in	FW	in fw-la NUPOS
vivo	FW	vivo fw-la NUPOS
.	.	. . NUPOS

Male	JJ	male JJ PennPOS
CD-1	NN	CD-1 NN PennPOS
mice	NNS	mouse n2 NUPOS
received	VBD	receive VBD PennPOS
intra-tracheal	JJ	intra-tracheal JJ PennPOS
bleomycin	NN	bleomycin NN PennPOS
(	(	( ( NUPOS
BLEO	NN	BLEO NN PennPOS
,	,	, , NUPOS
1	CD	1 crd NUPOS
mg/kg	NN	mg/kg NN PennPOS
)	)	) ) NUPOS
instillation	NN	instillation NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
absence	NN	absence NN PennPOS
or	CC	or cc NUPOS
presence	NN	presence NN PennPOS
of	IN	of pp-f NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
(	(	( ( NUPOS
a	DT	a dt NUPOS
dose	NN	dose NN PennPOS
of	IN	of pp-f NUPOS
0.6	CD	0.6 CD PennPOS
mg/kg	NN	mg/kg NN PennPOS
delivered	VBN	deliver VBN PennPOS
intra-peritoneally	RB	intra-peritoneal RB PennPOS
on	IN	on IN PennPOS
the	DT	the dt NUPOS
day	NN	day NN PennPOS
of	IN	of pp-f NUPOS
BLEO	NN	BLEO NN PennPOS
treatment	NN	treatment NN PennPOS
,	,	, , NUPOS
d0	NN	d0 NN PennPOS
,	,	, , NUPOS
followed	VBN	follow VBN PennPOS
by	IN	by IN PennPOS
bi-weekly	JJ	bi-weekly JJ PennPOS
additional	JJ	additional JJ PennPOS
doses	NNS	dose NNS PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

To	TO	to p-acp NUPOS
evaluate	VB	evaluate VBP PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
effects	NNS	effect NNS PennPOS
in	IN	in IN PennPOS
a	DT	a dt NUPOS
subset	NN	subset NN PennPOS
of	IN	of pp-f NUPOS
mice	NNS	mouse n2 NUPOS
,	,	, , NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
was	VBD	be vbd NUPOS
administered	VBN	administer VBN PennPOS
one	CD	one crd NUPOS
week	NN	week NN PennPOS
after	IN	after c-acp NUPOS
BLEO	NN	BLEO NN PennPOS
instillation	NN	instillation NN PennPOS
(	(	( ( NUPOS
d7	NN	d7 NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Animals	NNS	animal NNS PennPOS
were	VBD	be vbd NUPOS
sacrificed	VBN	sacrifice vvn NUPOS
at	IN	at pp NUPOS
one	CD	one crd NUPOS
,	,	, , NUPOS
two	CD	two crd NUPOS
,	,	, , NUPOS
or	CC	or cc NUPOS
three	CD	three crd NUPOS
weeks	NNS	week NNS PennPOS
later	RB	late RBR PennPOS
.	.	. . NUPOS

Measurement	NN	measurement NN PennPOS
of	IN	of pp-f NUPOS
fluid	NN	fluid NN PennPOS
and	CC	and cc NUPOS
collagen	NN	collagen NN PennPOS
content	NN	content NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lung	NN	lung NN PennPOS
,	,	, , NUPOS
Broncho	NNP	broncho NN PennPOS
Alveolar	JJ	alveolar JJ PennPOS
Lavage	NN	lavage NN PennPOS
Fluid	NN	fluid NN PennPOS
(	(	( ( NUPOS
BALF	NN	BALF NN PennPOS
)	)	) ) NUPOS
analysis	NN	analysis NN PennPOS
,	,	, , NUPOS
lung	NN	lung NN PennPOS
histology	NN	histology NN PennPOS
,	,	, , NUPOS
immunohistochemistry	NN	immunohistochemistry NN PennPOS
(	(	( ( NUPOS
IHC	NN	IHC NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
molecular	JJ	molecular JJ PennPOS
analysis	NN	analysis NN PennPOS
were	VBD	be vbd NUPOS
performed	VBN	perform VBN PennPOS
.	.	. . NUPOS

Compared	VBN	compare VBN PennPOS
to	TO	to p-acp NUPOS
BLEO-treated	JJ	bleo-treated JJ PennPOS
mice	NNS	mouse n2 NUPOS
,	,	, , NUPOS
animals	NNS	animal NNS PennPOS
that	WDT	that WDT PennPOS
received	VBD	receive VBD PennPOS
also	RB	also av NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
(	(	( ( NUPOS
at	IN	at pp NUPOS
both	DT	both d NUPOS
d0	NN	d0 NN PennPOS
and	CC	and cc NUPOS
d7	NN	d7 NN PennPOS
)	)	) ) NUPOS
had	VBD	have vhd NUPOS
significantly	RB	significant av-j NUPOS
decreased	VBN	decrease VBN PennPOS
mortality	NN	mortality NN PennPOS
,	,	, , NUPOS
weight	NN	weight NN PennPOS
loss	NN	loss NN PennPOS
,	,	, , NUPOS
inflammation	NN	inflammation NN PennPOS
(	(	( ( NUPOS
edema	NN	edema NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
leukocyte	NN	leukocyte NN PennPOS
lung	NN	lung NN PennPOS
infiltration	NN	infiltration NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
lung	NN	lung NN PennPOS
damage	NN	damage NN PennPOS
(	(	( ( NUPOS
histological	JJ	histological JJ PennPOS
evidence	NN	evidence NN PennPOS
of	IN	of pp-f NUPOS
lung	NN	lung NN PennPOS
injury	NN	injury NN PennPOS
)	)	) ) NUPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
collagen	NN	collagen NN PennPOS
histological	JJ	histological JJ PennPOS
staining	NN	staining NN PennPOS
and	CC	and cc NUPOS
soluble	JJ	soluble JJ PennPOS
collagen	NN	collagen NN PennPOS
content	NN	content NN PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
lung	NN	lung NN PennPOS
)	)	) ) NUPOS
at	IN	at pp NUPOS
up	RB	up a-acp NUPOS
to	TO	to p-acp NUPOS
21	CD	21 crd NUPOS
days	NNS	day n2 NUPOS
.	.	. . NUPOS

Moreover	RB	moreover av NUPOS
,	,	, , NUPOS
IHC	NNP	IHC NNP PennPOS
and	CC	and cc NUPOS
quantitative	JJ	quantitative JJ PennPOS
RT-PCR	NN	rt-pcr NN PennPOS
results	VBZ	result VBZ PennPOS
demonstrated	VBD	demonstrate VBD PennPOS
a	DT	a dt NUPOS
significant	JJ	significant JJ PennPOS
decrease	NN	decrease NN PennPOS
in	IN	in IN PennPOS
BLEO-induced	JJ	bleo-induced JJ PennPOS
IL-17	NN	IL-17 NN PennPOS
and	CC	and cc NUPOS
TGF-b	NN	TGF-b NN PennPOS
expression	NN	expression NN PennPOS
in	IN	in IN PennPOS
lung	NN	lung NN PennPOS
tissue	NN	tissue NN PennPOS
.	.	. . NUPOS

Importantly	RB	important av-j NUPOS
,	,	, , NUPOS
a-SMA	NN	a-SMA NN PennPOS
expression	NN	expression NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
hallmark	NN	hallmark NN PennPOS
of	IN	of pp-f NUPOS
myofibroblast	NN	myofibroblast NN PennPOS
differentiation	NN	differentiation NN PennPOS
,	,	, , NUPOS
was	VBD	be vbd NUPOS
also	RB	also av NUPOS
decreased	VBN	decrease VBN PennPOS
.	.	. . NUPOS

This	DT	this d NUPOS
is	VBZ	be vbz NUPOS
the	DT	the dt NUPOS
first	JJ	first JJ PennPOS
report	NN	report NN PennPOS
showing	VBG	show VBG PennPOS
not	RB	not xx NUPOS
only	RB	only av-j NUPOS
a	DT	a dt NUPOS
preventive	JJ	preventive JJ PennPOS
protective	JJ	protective JJ PennPOS
role	NN	role NN PennPOS
of	IN	of pp-f NUPOS
Ac-SDKP	NN	Ac-SDKP NN PennPOS
but	CC	but cc-acp NUPOS
also	RB	also av NUPOS
its	PRP$	its po31 NUPOS
significant	JJ	significant JJ PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
effects	NNS	effect NNS PennPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
bleomycin	NN	bleomycin NN PennPOS
model	NN	model NN PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
,	,	, , NUPOS
thus	RB	thus av NUPOS
supporting	VBG	support VBG PennPOS
further	JJ	further JJ PennPOS
preclinical	JJ	preclinical JJ PennPOS
and	CC	and cc NUPOS
clinical	JJ	clinical JJ PennPOS
studies	NNS	study NNS PennPOS
.	.	. . NUPOS

